Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galvani Bioelectronics
Stevenage, Hertfordshire, United Kingdomgalvani.bio ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Successfully implanted and began treatment in the world's first patient receiving experimental therapy for Rheumatoid Arthritis using splenic nerve stimulation. A US-based randomized and double-blinded feasibility study has also been initiated to assess safety and effectiveness of the platform.
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularUrologyRheumatologyImmunologyEndocrinologyOtherNeurology
- Modalities
- Bioelectronic medicinesNeuromodulation therapiesImplantable devices
- Industry
- Implantable Medical Devices
02
Partnerships
GlaxoSmithKline (GSK)Verily Life Sciences (formerly Google Life Sciences)
Beyond the preview
Go deeper on Galvani Bioelectronics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Galvani Bioelectronics.